Active immunization toward the MAGE-A3 antigen in patients with metastatic melanoma: Four-year follow-up results from a randomized phase II study (EORTC16032-18031).

8535 Background: Active immunization towards MAGE-A3 tumor antigen is a potential new approach to treat cancer. Current data from pilot studies have shown that a strong and persistent immune respon...